Kardigan, Inc.

NASDAQ:KARD

Biotechnology

Healthcare
$12.32 +3.50%

+$0.77 today

Market cap
$1.10B
Beta
0.00
52W Low $16.25High $24.00

Volume 0.55M

Average 5.84M

KARD Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

No reported Operating Expenses figures are available to summarize.

Operating Expenses history

Currency unavailable · from the income statement

No Operating Expenses data reported for this period type.

Operating Expenses vs competitors

How KARD compares with its peers on the latest reported figures

KARD Competitors
Operating Expenses for KARD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CYTKCytokinetics, IncorporatedLTM Jun 2026$767.6M USD+21.3%+57.1%1081.7%
NAMSNewAmsterdam Pharma Company N.V.LTM Jun 2026$250.97M USD+6.0%+32.7%3524.4%
RNAAtrium Therapeutics, Inc.FY2025$95.43M USD——512.6%
TNYATenaya Therapeutics, Inc.LTM Mar 2026$86.18M USD-19.9%-10.1%38304.0%
IKTInhibikase Therapeutics, Inc.LTM Mar 2026$55.59M USD+44.8%+41.8%—
KARDKardigan, Inc.—— ———
Peer median (excluding KARD) —+13.7%+37.2%2303.0%

Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kardigan, Inc.

NASDAQ:KARD

Intrinsic Alpha fair value

Locked

Current Price

$12.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.